Annual FCF
-$39.49 M
-$21.33 M-117.54%
31 December 2023
Summary:
Dare Bioscience annual free cash flow is currently -$39.49 million, with the most recent change of -$21.33 million (-117.54%) on 31 December 2023. During the last 3 years, it has fallen by -$14.23 million (-56.37%). DARE annual FCF is now -10505.99% below its all-time high of -$372.30 thousand, reached on 31 December 2016.DARE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$5.64 M
-$18.26 M-144.71%
30 September 2024
Summary:
Dare Bioscience quarterly free cash flow is currently -$5.64 million, with the most recent change of -$18.26 million (-144.71%) on 30 September 2024. Over the past year, it has increased by +$2.35 million (+29.44%). DARE quarterly FCF is now -122.78% below its all-time high of $24.77 million, reached on 30 September 2016.DARE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$8.63 M
+$2.35 M+21.43%
30 September 2024
Summary:
Dare Bioscience TTM free cash flow is currently -$8.63 million, with the most recent change of +$2.35 million (+21.43%) on 30 September 2024. Over the past year, it has increased by +$27.97 million (+76.42%). DARE TTM FCF is now -135.31% below its all-time high of $24.44 million, reached on 30 June 2017.DARE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DARE Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -117.5% | +29.4% | +76.4% |
3 y3 years | -56.4% | -532.1% | +69.3% |
5 y5 years | -284.1% | -77.4% | +29.4% |
DARE Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -117.5% | at low | -144.7% | +65.0% | at high | +78.2% |
5 y | 5 years | -284.1% | at low | -144.7% | +65.0% | at high | +78.2% |
alltime | all time | <-9999.0% | at low | -122.8% | +65.0% | -135.3% | +79.1% |
Dare Bioscience Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$5.64 M(-144.7%) | -$8.63 M(-21.4%) |
June 2024 | - | $12.62 M(-285.0%) | -$10.98 M(-63.6%) |
Mar 2024 | - | -$6.82 M(-22.4%) | -$30.19 M(-23.5%) |
Dec 2023 | -$39.49 M(+117.5%) | -$8.79 M(+9.9%) | -$39.49 M(+7.9%) |
Sept 2023 | - | -$8.00 M(+21.4%) | -$36.60 M(+82.5%) |
June 2023 | - | -$6.59 M(-59.1%) | -$20.06 M(-8.5%) |
Mar 2023 | - | -$16.12 M(+173.2%) | -$21.92 M(+20.8%) |
Dec 2022 | -$18.15 M(-36.9%) | -$5.90 M(-169.0%) | -$18.15 M(-18.1%) |
Sept 2022 | - | $8.55 M(-201.1%) | -$22.17 M(-24.6%) |
June 2022 | - | -$8.45 M(-31.6%) | -$29.41 M(-10.2%) |
Mar 2022 | - | -$12.35 M(+24.5%) | -$32.75 M(+13.8%) |
Dec 2021 | -$28.78 M(+14.0%) | -$9.92 M(-859.4%) | -$28.78 M(+2.6%) |
Sept 2021 | - | $1.31 M(-111.1%) | -$28.06 M(-19.2%) |
June 2021 | - | -$11.79 M(+40.8%) | -$34.72 M(+28.4%) |
Mar 2021 | - | -$8.38 M(-8.9%) | -$27.03 M(+7.0%) |
Dec 2020 | -$25.25 M(+89.6%) | -$9.20 M(+71.7%) | -$25.25 M(+27.1%) |
Sept 2020 | - | -$5.36 M(+30.6%) | -$19.87 M(+12.3%) |
June 2020 | - | -$4.10 M(-37.8%) | -$17.69 M(+6.5%) |
Mar 2020 | - | -$6.60 M(+73.2%) | -$16.60 M(+24.7%) |
Dec 2019 | -$13.32 M(+29.5%) | -$3.81 M(+19.8%) | -$13.32 M(+9.0%) |
Sept 2019 | - | -$3.18 M(+5.4%) | -$12.22 M(+3.6%) |
June 2019 | - | -$3.02 M(-8.8%) | -$11.79 M(+2.8%) |
Mar 2019 | - | -$3.31 M(+22.1%) | -$11.47 M(+11.6%) |
Dec 2018 | -$10.28 M | -$2.71 M(-1.6%) | -$10.28 M(+20.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2018 | - | -$2.75 M(+2.1%) | -$8.53 M(+18.6%) |
June 2018 | - | -$2.70 M(+27.3%) | -$7.20 M(+56.1%) |
Mar 2018 | - | -$2.12 M(+120.5%) | -$4.61 M(+81.4%) |
Dec 2017 | -$2.54 M(+582.3%) | -$961.10 K(-32.3%) | -$2.54 M(+45.5%) |
Sept 2017 | - | -$1.42 M(+1194.6%) | -$1.75 M(-107.1%) |
June 2017 | - | -$109.60 K(+116.6%) | $24.44 M(+85.2%) |
Mar 2017 | - | -$50.60 K(-69.7%) | $13.20 M(-3644.5%) |
Dec 2016 | -$372.30 K(-98.8%) | -$167.00 K(-100.7%) | -$372.30 K(-95.6%) |
Sept 2016 | - | $24.77 M(-318.1%) | -$8.55 M(-79.3%) |
June 2016 | - | -$11.35 M(-16.6%) | -$41.32 M(+9.2%) |
Mar 2016 | - | -$13.62 M(+63.2%) | -$37.84 M(+17.5%) |
Dec 2015 | -$32.19 M(+66.9%) | -$8.35 M(+4.3%) | -$32.19 M(+8.9%) |
Sept 2015 | - | -$8.00 M(+1.6%) | -$29.56 M(+8.7%) |
June 2015 | - | -$7.88 M(-1.2%) | -$27.20 M(+15.4%) |
Mar 2015 | - | -$7.97 M(+39.4%) | -$23.58 M(+22.2%) |
Dec 2014 | -$19.29 M(+16.0%) | -$5.72 M(+1.4%) | -$19.29 M(+14.5%) |
Sept 2014 | - | -$5.64 M(+32.5%) | -$16.84 M(+16.7%) |
June 2014 | - | -$4.25 M(+15.6%) | -$14.43 M(-8.1%) |
Mar 2014 | - | -$3.68 M(+12.5%) | -$15.70 M(-5.6%) |
Dec 2013 | -$16.62 M(-21.5%) | -$3.27 M(+1.5%) | -$16.62 M(+24.5%) |
Sept 2013 | - | -$3.22 M(-41.7%) | -$13.35 M(+31.8%) |
June 2013 | - | -$5.52 M(+20.0%) | -$10.13 M(+120.0%) |
Mar 2013 | - | -$4.60 M | -$4.60 M |
Dec 2012 | -$21.18 M | - | - |
FAQ
- What is Dare Bioscience annual free cash flow?
- What is the all time high annual FCF for Dare Bioscience?
- What is Dare Bioscience annual FCF year-on-year change?
- What is Dare Bioscience quarterly free cash flow?
- What is the all time high quarterly FCF for Dare Bioscience?
- What is Dare Bioscience quarterly FCF year-on-year change?
- What is Dare Bioscience TTM free cash flow?
- What is the all time high TTM FCF for Dare Bioscience?
- What is Dare Bioscience TTM FCF year-on-year change?
What is Dare Bioscience annual free cash flow?
The current annual FCF of DARE is -$39.49 M
What is the all time high annual FCF for Dare Bioscience?
Dare Bioscience all-time high annual free cash flow is -$372.30 K
What is Dare Bioscience annual FCF year-on-year change?
Over the past year, DARE annual free cash flow has changed by -$21.33 M (-117.54%)
What is Dare Bioscience quarterly free cash flow?
The current quarterly FCF of DARE is -$5.64 M
What is the all time high quarterly FCF for Dare Bioscience?
Dare Bioscience all-time high quarterly free cash flow is $24.77 M
What is Dare Bioscience quarterly FCF year-on-year change?
Over the past year, DARE quarterly free cash flow has changed by +$2.35 M (+29.44%)
What is Dare Bioscience TTM free cash flow?
The current TTM FCF of DARE is -$8.63 M
What is the all time high TTM FCF for Dare Bioscience?
Dare Bioscience all-time high TTM free cash flow is $24.44 M
What is Dare Bioscience TTM FCF year-on-year change?
Over the past year, DARE TTM free cash flow has changed by +$27.97 M (+76.42%)